Sodium-glucose cotransporter 2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes - a systematic review and metaanalysis of randomized controlled trials
Favorite
Share
More Options
21

Open in WPS to view all 21 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
